Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma
出版年份 2013 全文链接
标题
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 42, Issue 4, Pages 1297-1304
出版商
Spandidos Publications
发表日期
2013-02-22
DOI
10.3892/ijo.2013.1840
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
- (2012) Michael Heise et al. BMC CANCER
- Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma
- (2011) Min-A Seol et al. BMC CANCER
- Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population
- (2011) R. Cui et al. GUT
- Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib
- (2011) D. L. White et al. HAEMATOLOGICA
- DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
- (2011) Elke Schaeffeler et al. Genome Medicine
- Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines
- (2010) Ling Xu et al. BMC CANCER
- Functional Analysis of Human Organic Cation Transporter OCT3 (SLC22A3) Polymorphisms
- (2010) Takeshi Sakata et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
- (2010) Birgit Gruenberger et al. LANCET ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
- (2010) Ligong Chen et al. Pharmacogenetics and Genomics
- JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma
- (2009) Qingshan Chang et al. Molecular Cancer
- Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
- (2008) S. Yokoo et al. DRUG METABOLISM AND DISPOSITION
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes
- (2008) I. S. Song et al. XENOBIOTICA
- Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
- (2008) S.A. Khan et al. HPB
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started